![](/img/cover-not-exists.png)
Safety and activity of ibrutinib in combination with durvalumab in patients with relapsed or refractory follicular lymphoma or diffuse large B‐cell lymphoma
Herrera, Alex F., Goy, Andre, Mehta, Amitkumar, Ramchandren, Radhakrishnan, Pagel, John M., Svoboda, Jakub, Guan, Shanhong, Hill, John S., Kwei, Kevin, Liu, Emily A., Phillips, TycelJournal:
American Journal of Hematology
DOI:
10.1002/ajh.25659
Date:
October, 2019
File:
PDF, 1.43 MB
2019